Autoimmune fasciitis triggered by the anti-programmed cell death-1 monoclonal antibody nivolumab
Author:
Publisher
BMJ
Subject
General Medicine
Reference9 articles.
1. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial;Robert;Lancet,2014
2. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination;Boutros;Nat Rev Clin Oncol,2016
3. Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: a systematic review of the literature;Cappelli;Arthritis Care Res,2017
4. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort;Dobloug;Semin Arthritis Rheum,2015
5. Myalgia in patients with dermatomyositis and polymyositis is attributable to fasciitis rather than myositis: a retrospective study of 32 patients who underwent histopathological examinations;Noda;J Rheumatol,2017
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Eosinophilic fasciitis as an immune-related adverse event of Pembrolizumab in Hodgkin’s lymphoma: a case report;Khyber Medical University Journal;2024-06-30
2. Nivolumab-induced eosinophilic fasciitis: An unusual immune-related adverse event that needs to be recognized by practitioners;Annales de Dermatologie et de Vénéréologie;2023-12
3. Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics;Pharmaceuticals;2023-02-08
4. Eosinophilic Fasciitis: Current and Remaining Challenges;International Journal of Molecular Sciences;2023-01-19
5. Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced “Eosinophilic Fasciitis-Like” Case and a Review of the Literature;Rheumatology and Therapy;2020-10-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3